Comments
Loading...
Aditxt (NASDAQ:ADTX) Stock Quotes, Forecast and News Summary
Aditxt Stock (NASDAQ: ADTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aditxt (ADTX) stock?
You can purchase shares of Aditxt (NASDAQ:ADTX) through any online brokerage.
Who are Aditxt (ADTX) competitors?
Other companies in Aditxt’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for Aditxt (ADTX) stock?
Aditxt has a consensus price target of $61.00.
What is the current price for Aditxt (ADTX)?
The stock price for Aditxt (NASDAQ: ADTX) is $0.1895 last updated December 24, 2024 at 11:09 AM EST.
Does Aditxt (ADTX) pay a dividend?
There are no upcoming dividends for Aditxt.
When is Aditxt (NASDAQ:ADTX) reporting earnings?
Aditxt’s Q3 earnings are confirmed for Monday, November 18, 2024.
Is Aditxt (ADTX) going to split?
There is no upcoming split for Aditxt.
What sector and industry does Aditxt (ADTX) operate in?
Aditxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.